Table 1.
Baseline characteristics of eligible studies evaluating RASSF1A hypermethylation and OS or DFS in breast cancer patients.
Table 2.
Main results of eligible studies evaluating RASSF1A hypermethylation and OS/DFS in breast cancer patients.
Figure 1.
Forest plot showing the association between RASSF1A methylation and overall survival (OS) of breast cancer.
The summary HR and 95% CIs were shown (according to the random-effects estimations).
Figure 2.
Forest plot showing the association between RASSF1A methylation and disease-free survival (DFS) of breast cancer.
The summary HR and 95% CIs were shown (according to the fixed-effects estimations).
Figure 3.
Forest plot showing the association between RASSF1A methylation and overall survival (OS) of breast cancer calculating from the data of multivariate Cox regression analyses.
Figure 4.
Forest plot showing the association between RASSF1A methylation and disease-free survival (DFS) of breast cancer calculating from the data of multivariate Cox regression analyses.